MiR-7-5p targeted Rb regulating cell cycle is involved in hydroquinone-induced malignant progression in human

Lu Zhai1, Yuting Gao1, Zheming Cui1

  • 1Department of Environmental and Occupational Health, Dongguan Key Laboratory of Environmental Medicine, School of Public Health, Guangdong Medical University, Dongguan, China.

Insights

MicroRNA-7-5p (miR-7-5p) can inhibit cancer development. This study shows miR-7-5p overexpression counteracts hydroquinone-induced malignant changes in TK6 cells by slowing cell cycle progression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Toxicology

Background:

  • MicroRNA-7-5p (miR-7-5p) inhibits tumorigenesis.
  • The effect of miR-7-5p on hydroquinone (HQ)-induced malignant transformation in TK6 cells is unknown.

Purpose of the Study:

  • To investigate if miR-7-5p overexpression can prevent HQ-induced malignant phenotype in TK6 cells.
  • To explore the underlying molecular mechanisms.

Main Methods:

  • TK6 cells were exposed to HQ.
  • miR-7-5p expression levels were measured.
  • Cell cycle progression and the Rb/E2F1 pathway were analyzed.

Main Results:

  • HQ suppressed miR-7-5p expression and accelerated cell cycle progression.
  • miR-7-5p overexpression decelerated cell cycle progression by targeting Rb.
  • miR-7-5p mitigated HQ-induced malignant phenotype by impeding cell cycle progression via the Rb/E2F1 pathway.

Conclusions:

  • miR-7-5p overexpression inhibits HQ-induced malignant transformation in TK6 cells.
  • This effect is mediated by the suppression of the Rb/E2F1 signaling pathway and deceleration of cell cycle progression.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K